RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
RT @TheLancet: Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epile…
Two trials published in Lancet journals have shown a benefit of #cannabidiol for #epilepsy—one for treatment-resistant epilepsy published in @TheLancetNeuro https://t.co/0Vriz0E1w5 and one for Lennox-Gastaut syndrome https://t.co/FKL8vp99Rr https://t.co/9
RT @ClintonJPowers: @djntype @UKChange This is true CBD has great findings backing its medical potential. https://t.co/zRQH9oehUP
@djntype @UKChange This is true CBD has great findings backing its medical potential. https://t.co/zRQH9oehUP
@katebevan Found this informative https://t.co/d9a1oMyhBy
RT @Epilepsy_Durham: Cannabidiol in patients with seizures associated with #LennoxGastaut syndrome (GWPCARE4): a randomised, double-blind,…
@katebevan The FDA recommended approval in April of of an epilepsy medication called Epidiolex. The Lancet published a study on it. https://t.co/sfd1qclagG
RT @MarcGozlan: Syndrome de Lennox–Gastaut de l'enfant et de l'adulte (forme rare et sévère d'encéphalopathie épileptique) : l'ajout de ca…
RT @MarcGozlan: Syndrome de Lennox–Gastaut de l'enfant et de l'adulte (forme rare et sévère d'encéphalopathie épileptique) : l'ajout de ca…
RT @MarcGozlan: Syndrome de Lennox–Gastaut de l'enfant et de l'adulte (forme rare et sévère d'encéphalopathie épileptique) : l'ajout de ca…
Syndrome de Lennox–Gastaut de l'enfant et de l'adulte (forme rare et sévère d'encéphalopathie épileptique) : l'ajout de cannabidiol réduit la fréquence des crises ("drop seizures") https://t.co/5gXjmbqmEi via @NEJM + https://t.co/3Nv8e63vBP via @TheLancet
GWPCARE4: Étude de phase III sur l'utilisation du cannabidiol comme traitement anti-épileptique chez des patients avec le Syndrome de Lennox-Gastaut. https://t.co/n3OnGy1IVs
RT @Epilepsy_Durham: Cannabidiol in patients with seizures associated with #LennoxGastaut syndrome (GWPCARE4): a randomised, double-blind,…
RT @Obscannamed: Investigadores del Programa de Epilepsia Pediátrica en el Hospital General de Massachusetts de Boston concluyen diciendo "…
RT @Obscannamed: Investigadores del Programa de Epilepsia Pediátrica en el Hospital General de Massachusetts de Boston concluyen diciendo "…
RT @Obscannamed: Investigadores del Programa de Epilepsia Pediátrica en el Hospital General de Massachusetts de Boston concluyen diciendo "…
Investigadores del Programa de Epilepsia Pediátrica en el Hospital General de Massachusetts de Boston concluyen diciendo "el CBD como complemento es eficaz para el tratamiento de pacientes con crisis epilépticas asociadas con el síndrome de Lennox-Gastaut"
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/MeotQY5dyP
RT @sarc092: Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-…
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/mlTtqZUW8C
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Comment: Cannabidiol for drop #seizures in Lennox-Gastaut syndrome https://t.co/BsmKfI7DsT https://t.co/po3NyLXOwf
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
RT @CarstenLincke: Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Ga…
Gaat @ZiNLActueel nu eindelijk advies aan @MinVWS mbt tot vergoeding herzien? Cannabidiol in patients with ... Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/h1mD3AKLuh #epilepsie @wijzienjewel
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Comment: Cannabidiol for drop #seizures in Lennox-Gastaut syndrome https://t.co/BsmKfI7DsT https://t.co/po3NyLXOwf
RT @TheLancet: Comment: Cannabidiol for drop #seizures in Lennox-Gastaut syndrome https://t.co/BsmKfI7DsT https://t.co/po3NyLXOwf
RT @TheLancet: Comment: Cannabidiol for drop #seizures in Lennox-Gastaut syndrome https://t.co/BsmKfI7DsT https://t.co/po3NyLXOwf
Comment: Cannabidiol for drop #seizures in Lennox-Gastaut syndrome https://t.co/BsmKfI7DsT https://t.co/po3NyLXOwf
Intersting! https://t.co/1oV38fMmQq
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
Wow, there it is- #cannabidiol shows significant seizure reduction compared with placebo https://t.co/S5VHsq9Yks
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
"Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syndrome and is generally well tolerated. The long-term efficacy and safety of cannabidiol is currently being assessed..." https://t.co/fZx2k
#LennoxGastautsyndrome Recomendo a leitura https://t.co/QGqya2bmyp
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
RT @drng: The median percentage reduction in monthly drop seizure frequency from baseline was 43·9% (IQR −69·6 to −1·9) in the cannibidiol…
The median percentage reduction in monthly drop seizure frequency from baseline was 43·9% (IQR −69·6 to −1·9) in the cannibidiol group and 21·8% (IQR −45·7 to 1·7) in the placebo group. ping @DanielAndrewsMP @normanswan @sophiescott2 https://t.co/O1OfVFdy
RT @TheLancet: Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placeb…
Cannabidiol in patients with #seizures associated with #LennoxGastautsyndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial — in this week's issue https://t.co/kC9tR0jq6o
Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/MPaKdp3DRd #Medicine
RT @alexisrebdo: El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociada…
RT @alexisrebdo: El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociada…
RT @alexisrebdo: El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociada…
RT @alexisrebdo: El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociada…
RT @alexisrebdo: El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociada…
El cannabidiol reduce significativamente la frecuencia y la duración de los ataques en pacientes con convulsiones asociadas con el síndrome de Lennox-Gastaut https://t.co/vBF1atqt3u
https://t.co/xua9Oi3XgA Cannabidiol significantly reduces seizure frequency and duration in patients with seizures associated with Lennox-Gastaut syndrome: a randomised, double-blind, placebo-controlled phase 3 trial #sciencenews https://t.co/v3Q78QdPDV
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet https://t.co/G0nBhpKp5b #MedicalCannabis #MedicalMarijuana #CBD #lgs
RT @EpilepsiaHRI: Cannabidiol puede reducir las crisis con caída en los pacientes con Síndrome de Lennox-Gastaut Cannabidiol in patients wi…
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/zeaxw4UQFS
RT @MedCannResearch: "Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syn…
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial https://t.co/z0dDChQy9U
RT @MedCannResearch: "Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syn…
The Lancet「Lennox-Gastaut症候群に関連した発作に対するカンナビジオール:無作為割付・二重盲検・プラセボ対照試験」 https://t.co/OzvDRwRSu6 大麻由来製剤の使いどころは、難病によるてんかん発作ということになってゆくんだろうか。
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/sMD4wxYClu
RT @ProjectCBD: CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
CBD is effective against seizures in Lennox-Gastaut syndrome https://t.co/ct2s94gIRv
"Add-on cannabidiol is efficacious for the treatment of patients with drop seizures associated with Lennox-Gastaut syndrome and is generally well tolerated." - Lancet Jan 2018 https://t.co/FexGz6sobS https://t.co/wGoxZuRLOb
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…
RT @ACTINOSProject: The problem with writing conservative reviews on medicinal cannabis... https://t.co/2wUK6ga3Ya is that by the time the…